DK0410517T3 - Flydende nitrofurantoinsuspensioner - Google Patents

Flydende nitrofurantoinsuspensioner

Info

Publication number
DK0410517T3
DK0410517T3 DK90201966.0T DK90201966T DK0410517T3 DK 0410517 T3 DK0410517 T3 DK 0410517T3 DK 90201966 T DK90201966 T DK 90201966T DK 0410517 T3 DK0410517 T3 DK 0410517T3
Authority
DK
Denmark
Prior art keywords
nitrofurantoin
suspensions
liquid
monohydrate
particulates
Prior art date
Application number
DK90201966.0T
Other languages
English (en)
Inventor
Margaret Anne Mcgowan
Vijay Shahi
Michael John Kane
Original Assignee
Norwich Eaton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Eaton Pharma filed Critical Norwich Eaton Pharma
Application granted granted Critical
Publication of DK0410517T3 publication Critical patent/DK0410517T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
DK90201966.0T 1989-07-25 1990-07-18 Flydende nitrofurantoinsuspensioner DK0410517T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/385,646 US5178880A (en) 1989-07-25 1989-07-25 Liquid suspensions of nitrofurantoin

Publications (1)

Publication Number Publication Date
DK0410517T3 true DK0410517T3 (da) 1994-02-07

Family

ID=23522290

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90201966.0T DK0410517T3 (da) 1989-07-25 1990-07-18 Flydende nitrofurantoinsuspensioner

Country Status (11)

Country Link
US (1) US5178880A (da)
EP (1) EP0410517B1 (da)
AT (1) ATE97806T1 (da)
AU (1) AU635948B2 (da)
CA (1) CA2020812C (da)
DE (1) DE69004882T2 (da)
DK (1) DK0410517T3 (da)
ES (1) ES2060931T3 (da)
IE (1) IE63814B1 (da)
IL (1) IL95059A (da)
NZ (1) NZ234635A (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776343B1 (en) * 1999-02-17 2010-08-17 Csl Limited Immunogenic complexes and methods relating thereto

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE515245A (da) * 1950-05-29
US3401221A (en) * 1964-08-25 1968-09-10 Norwich Pharma Co Treatment of urinary tract infection
US4122157A (en) * 1977-03-04 1978-10-24 Richardson-Merrell Inc. Nitrofurantoin sustained release tablet
DE2714065A1 (de) * 1977-03-30 1978-10-12 Boehringer Mannheim Gmbh Instillationszubereitung
US4370313A (en) * 1981-10-26 1983-01-25 Eaton Laboratories, Inc. Nitrofurantoin dosage form
US4959384A (en) * 1985-10-24 1990-09-25 Norwich Eaton Pharmaceuticals, Inc. Use of nitrofurantoin for the treatment and prophylaxis of gastrointestinal disorders
US4798725A (en) * 1986-06-16 1989-01-17 Norwich Eaton Pharmaceuticals, Inc. Sustained release capsule
US4772473A (en) * 1986-06-16 1988-09-20 Norwich Eaton Pharmaceuticals, Inc. Nitrofurantoin dosage form

Also Published As

Publication number Publication date
ES2060931T3 (es) 1994-12-01
NZ234635A (en) 1993-10-26
CA2020812A1 (en) 1991-01-26
AU635948B2 (en) 1993-04-08
DE69004882T2 (de) 1994-05-19
IE902693A1 (en) 1991-02-27
DE69004882D1 (de) 1994-01-13
ATE97806T1 (de) 1993-12-15
IL95059A0 (en) 1991-06-10
EP0410517A1 (en) 1991-01-30
AU5975290A (en) 1991-01-31
CA2020812C (en) 1995-08-01
EP0410517B1 (en) 1993-12-01
US5178880A (en) 1993-01-12
IL95059A (en) 1994-07-31
IE63814B1 (en) 1995-06-14

Similar Documents

Publication Publication Date Title
MX173949B (es) Composiciones biocidas y agroquimicas
DK0602702T3 (da) Anvendelse af tyloxapol som nanopartikelstabilisator og dispergeringsmiddel
ATE174755T1 (de) Dosierungsmittel und dessen verwendung
ES2062417T3 (es) Composiciones farmaceuticas de cimetidina.
FI945081A0 (fi) Stabiili hydratoitu kefalosporiinikuivajauhe oraaliseen suspensioformulaatioon
ATE78691T1 (de) Sucralfat-suspension zur verwendung in der behandlung von geschwueren.
DK486189D0 (da) Psyllium-froeskaller og midler omfattende samme
DE59002861D1 (de) Verwendung von wasserlöslichen copolymerisaten aus monoethylenisch ungesättigten carbonsäuren und vinylimidazol(derivaten) als wasserbehandlungsmittel.
DK0410517T3 (da) Flydende nitrofurantoinsuspensioner
FR2694558B1 (fr) Monohydrate du sel disodique de l'acide 4-chlorophénylthiométhylène bisphosphonique, sa préparation, les compositions pharmaceutiques en contenant.
EP0129891A3 (en) New quinazolinone derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
IT8522027A0 (it) Composizioni farmaceutiche comprendenti acht (1-24) per il trattamento terapeutico degli stati di shock e dell'insufficienza respiratoria e cardiocircolatoria.
ATE33760T1 (de) Mittel zur oertlichen anwendung am koerper.
DK0412592T3 (da) Nitrofurantoinkrystaller
SE8302789D0 (sv) Oral tandvardskomposition
IT8723050A0 (it) Procedimento per la preparazione di sospensioni fluide stabili ed induribili e composizioni cosi'ottenute.
FR2556592B1 (fr) Compositions pharmaceutiques contenant des derives de l'acide campho-methylidene cinnamique
DE3784650D1 (de) Vorbeugende massnahmen zur verhinderung der "komplexen respiratorischen erkrankung bei rindern" durch verabreichung von interferon.
FR2541114B1 (fr) Compositions pharmaceutiques antifongiques utilisables par voie orale contenant de l'omoconazole
LV5177A3 (lv) Preparats "eridons" govju endometritu profilaksei un arstesanai
RU97111543A (ru) Способ лечения неврологических нарушений, связанных с хронической формой врожденной вирусной инфекции